Status:
NOT_YET_RECRUITING
Registry: TPLA for LUTS
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Conditions:
Lower Urinary Tract Symptoms
Benign Prostate Hyperplasia
Eligibility:
MALE
Brief Summary
Rationale: The treatment of lower urinary tract symptoms (LUTS) due to benign prostatic enlargement in men with transperineal laser ablation (TPLA) may offer advantages in functional outcomes and safe...
Eligibility Criteria
Inclusion
- Male
- Presenting with lower urinary tract symptoms
- Indication for transperineal laser ablation
- Signed informed consent form
Exclusion
- Age \< 18 years
- Previous or active treatment for prostate cancer (active surveillance is not seen as active treatment)
Key Trial Info
Start Date :
February 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2029
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03776006
Start Date
February 1 2019
End Date
February 1 2029
Last Update
January 18 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.